Desert Flame (Cannabis flos Medezin): what can be established and what cannot

Where does Desert Flame come from and who established its lineage?

It is unknown. In the lineage graph of this cluster, Desert Flame has parents marked as unknown: the breeder did not disclose them, and the collected strain databases either remain silent about it or provide conflicting versions. The trade name itself is not a clue and cannot replace the missing entry about its origin.

Such an entry is not a gap in the table that someone forgot to fill. Out of 85 cultivars described in this cluster, the lineage could be established for 60, while for 25 it remains unknown. There are usually two reasons: the breeder treats the cross as a trade secret, or the circulating descriptions attribute different parents to the same name, and no version can be considered established.

Reading the origin from the trade name is tempting, but it does not resolve anything. In the same grouping, the term kush is used by cultivars, half of which have documented parents, while the other half have none at all, so the common word in the name does not indicate kinship in any direction. Desert Flame does not even share such a term with another entry on the list, and even if it did, it would not be a basis for adding its parents.

For the reader, this means one limitation: nothing can be said about which family of strains this variety is closer to, nor what to expect from it based on its relatives. We maintain a current list of items that can be purchased today at the pharmacy in in the list of available medical marijuana strains.

Which manufacturer supplies Desert Flame to Polish pharmacies?

One. In the list of pharmacy items, Desert Flame appears exclusively under the brand Medezin and is the only strain from this manufacturer that we note in this cluster. One entry also means that there is no second version of the same cultivar to compare it with.

The absence of a second version is information in itself. Where the same cultivar is supplied by two manufacturers, it is evident how far apart the declarations on the packaging and sales descriptions for a plant bearing the same name can be. There is no such comparison for Desert Flame, so everything known about it comes from a single supply chain.

The presence of a product in a pharmacy is not a permanent state. Pharmacy-grade dried flower enters the market based on a permit with an expiration date, goes to wholesalers in batches, and disappears from the shelf when the batch runs out or when the manufacturer reshuffles the portfolio. Therefore, what can realistically be ordered today with a prescription is verified in the current comparison, not in the description of the strain, which ages more slowly. We write separately about the producer in a text about. Medezinie.

The declared THC content for this item is in the range of 18.0-22.0%. The manufacturer provides one nominal value, and regulations allow a deviation of one-tenth of that value in either direction, so an honest record is a range, not a number from the label. The value comes from a single source and pertains to this one item, not the strain in general.

The entry in the database requires one more caveat. The item is listed there under the name Amnesia Haze with the note Desert Flame in parentheses, so the description of the composition and potency is attributed to a term that does not exist as a separate strain in the Polish pharmacy list. Anyone searching under the name Desert Flame will not find this entry, even though it pertains exactly to this item.

A separate matter is the dried flower sold without a prescription, for example in the store category drought. It is a different type of product than pharmacy-grade raw material, subject to different regulations, and cannot be compared or substituted with the latter.

What does Desert Flame smell like and where do the descriptions of its taste come from?

We do not know, because none of the collected sources notes a single aromatic note for this item. The profile composition is described, but the description of the composition is not a description of the scent: it lists compounds present in the raw material, not the impression given by an opened package.

The composition is provided by one source and lists. myrcene, caryophyllene, limonene, humulene and pinene. The highest share is attributed to myrcene. The second of the collected sources for this position does not lead anywhere, so there is no confirmation from an independent source, and the entire composition description hangs on a single entry.

We do not transcribe the shares themselves. The entry provides them without indicating the whole, against which they are counted, and with other positions in this service, the same columns close on completely different sums. A fraction without a denominator looks like a reading from equipment, but it is an editorial weight.

Myrcene is often described as having an earthy and spicy note, sometimes with an accent of ripe fruit, but this is the characteristic of a chemical compound, not a measurement made on this strain. Transferring such a description to dried flower assumes that it is known how much of this compound is present compared to the others, and no one has provided that for Desert Flame.

The description of the scent is a report, not a parameter. The same dried flower smells different after longer storage, differently after grinding, and differently depending on who is smelling it, because volatile components decrease over time and with the surrounding temperature. The bases of strains can rewrite such descriptions from each other, which is why a single sentence from a breeder from years ago then returns as a fact on several pages.

With this strain, this path is closed for a simple reason: there is not even an original description of the scent that could be replicated. Instead of adding to it, we leave a blank space because an invented aroma would sound just as credible as a measured one.

How long does it take for the dried flower to start working and how long does it last?

This is determined by the route of administration, not the name on the packaging. Vaporization gives the first sensations within a few minutes, while swallowing takes several dozen. For Desert Flame itself, no one has made such a measurement, so what follows concerns the method of receiving the raw material and applies equally to any other strain.

The route of administration determines the course more than the variety itself. After vaporization, the substance passes from the lungs to the blood almost immediately, so the first sensations appear after a few minutes, the intensity increases for another ten to thirty minutes, and the whole effect lasts for two to four hours. After ingestion, the raw material first passes through the intestine and liver, so the first sensations are awaited from half an hour to two hours, and the episode can last six, sometimes eight hours. Hence the most common mistake with oral administration: anyone who thinks nothing is happening after thirty minutes and takes another dose will receive both doses at once. The above ranges describe the route of administration, not this variety; pharmacokinetic studies for a single cultivar have not been published.

For this strain, there is one more caveat. Since no one has described the composition of volatile compounds for it, there is not even material for speculation on whether it would shift the onset of effects. Only the route of administration remains, the same for every dried flower, and the interval between subsequent doses, which is determined by the attending physician.

What has been shown in studies on myrcene, and what has not?

Something has been shown about myrcene, not about Desert Flame. Three studies that we hold in the evidence base for this cluster concern a single terpene administered to mice, in doses and routes that do not have a counterpart in inhalation of dried flower. For the strain itself, there is not a single clinical or observational study.

The table describes the properties of the molecule, not the plant. Myrcene was administered to animals in isolation, in doses calculated per body weight, and dried flower carries dozens of other volatile compounds, the mutual influence of which none of these studies measured. The terpene profile of Desert Flame is not publicly documented, so there is not even a starting point for transferring such a conclusion to this position.

In humans, myrcene alone has not been shown to alleviate insomnia at doses typical for inhalation of dried flower. The direction of the effect in rodents depends on the route of administration and sex: intraperitoneal injection in 2002 described a slightly anxiogenic effect, while inhalation in 2024 showed an anxiolytic effect in females. These two results do not negate each other; they simply show that the conclusion depends on conditions that no popular strain database provides.

On the other side stands material that is not evidence. In the collected sources, there is not a single publication from the manufacturer about this product, and patient reports, if they exist, concern individual cases and specific batches with an unknown method of administration. We separate both sets precisely so that the second does not appear as an extension of the first.

What side effects have been reported for this strain?

None under this name. The supervision of pharmacotherapy safety organizes reports according to the medicinal product and batch number, and the cultivar name is not a separate entry, so there is no list of symptoms assigned exclusively to Desert Flame, and with the current data collection method, it cannot arise.

Reports of adverse effects are collected for medicinal products with a batch number, not for the strain name, so the following pertains to hemp dried flower as a group of raw materials. The most frequently reported symptoms are dry mouth, red eyes, and increased heart rate. Dizziness upon rapid standing, daytime drowsiness, and temporary worsening of short-term memory are less frequently described, as well as anxiety that increases with dosage. A separate issue is medications taken concurrently, especially sedatives and those affecting coagulation: their assessment requires knowledge of the entire list of preparations, not just the description of the plant. We do not provide the frequency of these symptoms numerically, as public compilations for hemp dried flower in Poland do not separate them by individual products.

There is nothing more regarding Desert Flame. This does not mean that the strain is milder or harsher than others: it only means that the question of its own safety profile currently has no recipient in the data. Symptoms should be reported to the attending physician, and suspicions of adverse effects of the medicinal product are also accepted by the registration office.

At what temperature does dried flower with a predominance of myrcene vaporize?

There is no single correct number here, as the vaporizer setting is not the temperature of the dried flower. Public chemical databases report that beta-myrcene boils around 166-167 °C at atmospheric pressure, but the conditions in the device's chamber are different, and the display shows readings from the heating element.

The boiling temperature indicates when a pure compound transitions to vapor under atmospheric pressure, not when it leaves the plant matrix. In dried flower, the same terpene is embedded in the matrix along with other components, gradually releasing below its boiling temperature and diminishing during the session. This is where tables assigning single values to terpenes come from, which can contradict each other when several are placed side by side. We outline this separately in a text about why. ustawienie waporyzatora does not equal the temperature of the dried flower, and in the comparison. of terpene evaporation temperatures..

With Desert Flame, there is a limitation known from previous sections. Since no complete composition has been published, it is impossible to say which compound will evaporate first at a given setting or what will remain in the chamber at the end of the session. A general principle remains, concerning the entire dried flower, not a guideline derived from this strain. We gathered more about myrcene in. osobnym opracowaniu.

Which strains are related to Desert Flame?

None that could be demonstrated. The list of related cultivars for this product is empty, and with unknown parents, there is nothing to build it on, as we derive siblings from the pedigree graph, and without an entry about the parents, the graph cannot connect this strain.

An empty list can also be a valid result even with a known pedigree. If the parents are landraces or broad style families, two cultivars sharing such an ancestor do not become siblings because they are categories, not identified individual strains. Among the 85 entries in this cluster, 29 have a non-empty list of connections.

With Desert Flame, however, the reason is different and needs to be separated. Here, the list is not empty because the parents turned out to be too broad a category, but because we do not know the parents at all. If the manufacturer were to reveal them someday, the graph could be completed in one place, and the connections would appear by themselves.

Until such a publication, Desert Flame stands in the comparison as a position without neighbors: without parents, without siblings, without a described composition. What the producer provides. opisujemy osobno, and we keep the entire list of strains in the comparison of currently available strains.

Frequently asked questions about Desert Flame.

Is Desert Flame indica or sativa?

This cannot be determined based on the collected sources. The pedigree of the strain remains undetermined, and without parents, there is nothing to classify. The division into these two categories is becoming less distinct with today's hybrids.

How many manufacturers supply Desert Flame to Polish pharmacies?

One, Medezin, and only in one product line. The composition of the offer can vary, so the current status is checked in the ongoing comparison of strains, not in the description of the strain itself.

What THC content is declared for Desert Flame?

A range of 18.0-22.0%. The manufacturer provides a single nominal value, and regulations allow a deviation of one-tenth in either direction, so a single number would appear to be a measurement, which it is not.

Is the terpene profile of Desert Flame described anywhere?

Yes, but it is described by only one source, and that under the name Amnesia Haze with the addition of Desert Flame. It lists myrcene, caryophyllene, limonene, humulene, and pinene, with the highest proportion of myrcene. The second source for this strain's profile does not exist.

Does myrcene have sedative effects?

This has not been demonstrated in humans at doses corresponding to the inhalation of dried flower. The studies we have relate to mice, and their results varied depending on the route of administration and the sex of the animals.

Can Desert Flame be purchased without a prescription?

No. Dried flower of pharmaceutical quality is available only by prescription from a doctor, in the Rpw category, and is not a retail product.

Hemp flower is a pharmaceutical raw material issued by prescription from a doctor in the Rpw category. The material is for informational purposes and does not replace advice from a doctor or pharmacist. Editorial text from the editorial team of ubucha.pl.